Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ADX:JULPHAR'
s Days Payable Range Over the Past 10 Years
Min: 77.44 Med: 111.63 Max: 194.3
Current: 194.3
During the past 13 years, Gulf Pharmaceutical Industries PSC's highest Days Payable was 194.30. The lowest was 77.44. And the median was 111.63.
ADX:JULPHAR's Days Payable is ranked better than 89.92% of 119
companies
in the Medical Distribution industry
Industry Median: 78.2
vs ADX:JULPHAR: 194.30
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gulf Pharmaceutical Industries PSC Days Payable Chart
ADX:JULPHAR vs MCK, COR, CAH: Days Payable Comparison
For the Medical Distribution subindustry, Gulf Pharmaceutical Industries PSC's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gulf Pharmaceutical Industries PSC Days Payable vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Gulf Pharmaceutical Industries PSC's Days Payable distribution charts can be found below:
* The bar in red indicates where Gulf Pharmaceutical Industries PSC's Days Payable falls into.
Gulf Pharmaceutical Industries PSC Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) has a Days Payable of 249.70 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Gulf Pharmaceutical Industries PSC and its competitors. This is 124% above median its historical median of 111.63. Over the past decade, Gulf Pharmaceutical Industries PSC's Days Payable has ranged from 77.44 to 194.30. According to the industry distribution chart, Gulf Pharmaceutical Industries PSC ranks #12 out of 119 companies in the Medical Distribution industry, placing it in the top 10.1%.
Is Gulf Pharmaceutical Industries PSC's Days Payable too high?
Gulf Pharmaceutical Industries PSC's current Days Payable of 249.70 is 124% above median its 10-year median of 111.63. Over the past 10 years, this metric has ranged from a low of 77.44 to a high of 194.30. The Medical Distribution industry median Days Payable is 78.20. Gulf Pharmaceutical Industries PSC's value of 249.70 is 219.3% above this industry median. Based on the distribution chart, Gulf Pharmaceutical Industries PSC ranks #12 out of 119 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Gulf Pharmaceutical Industries PSC has a GF Score™ of 64/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Gulf Pharmaceutical Industries PSC's Days Payable compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Gulf Pharmaceutical Industries PSC ranks #12 out of 119 companies for Days Payable. This places Gulf Pharmaceutical Industries PSC in the top 10% of its industry — outperforming the majority of peers. The industry median Days Payable is 78.20. Gulf Pharmaceutical Industries PSC's value of 249.70 is 219.3% above this benchmark. Historically, Gulf Pharmaceutical Industries PSC's own Days Payable has ranged from 77.44 to 194.30 over the past decade. While the company's 10-year median is 111.63 vs. the industry median of 78.20, Gulf Pharmaceutical Industries PSC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Distribution company?
The median Days Payable among Medical Distribution companies is 78.20, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gulf Pharmaceutical Industries PSC's current Days Payable of 249.70 is 219.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Gulf Pharmaceutical Industries PSC and its competitors. For the Medical Distribution industry, the median Days Payable is 78.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gulf Pharmaceutical Industries PSC's current Days Payable is 249.70, which is 124% above median its own 10-year median of 111.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gulf Pharmaceutical Industries PSC stock overvalued right now?
Based on GuruFocus' analysis, Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) is currently considered Fairly Valued. The stock's GF Value™ is د.إ1.12, compared to a current price of د.إ1.06 — trading 5.4% below its estimated fair value. The current Days Payable is 249.70, which is 124% above median its 10-year median of 111.63 and 219.3% above the Medical Distribution industry median of 78.20. Gulf Pharmaceutical Industries PSC's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Gulf Pharmaceutical Industries PSC (ADX:JULPHAR), the current Days Payable is 249.70 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Overvalued in 2026?
Based on GuruFocus' analysis, Gulf Pharmaceutical Industries PSC stock appears to be undervalued.
The current stock price of د.إ1.06 is trading 5.4% below its estimated GF Value™ of د.إ1.12.
GuruFocus considers Gulf Pharmaceutical Industries PSC to be Fairly Valued.
Key valuation signals for ADX:JULPHAR:
Days Payable: 249.70 (124% above median its 10-year median of 111.63)
GF Value™: د.إ1.12 vs. price of د.إ1.06 (5.4% below fair value)
Industry Position: 219.3% above the Medical Distribution median (#12 of 119)
No single metric tells the full story. See the ADX:JULPHAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gulf Pharmaceutical Industries PSC is in the business of manufacturing and selling medicines, drugs, and various other types of pharmaceutical and medical compounds in addition to cosmetic compounds. The company operates in four segments: Manufacturing, Trading, Investments, and others. The majority of its revenue is generated from the Manufacturing segment. The geographical segments are UAE, Other GCC countries, and Other countries. It derives maximum revenue from UAE. Its business is centered around General Medicines in the retail pharmacy channel and hospitals as well as speciality Products. Its medicines also targets therapeutic segments such as Diabetes, Gastrointestinal Tract (GIT), Respiratory, Wounds and Scars, Anti-infectives, Anemia, Gynecology, Erectile Dysfunction and Others.
64GF Score
Get the complete analysis for ADX:JULPHAR
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ADX:JULPHAR has been successfully added to your 
